Ranibizumab in neovascular age-related macular degeneration.
about
MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesisMonoclonal antibodies - a proven and rapidly expanding therapeutic modality for human diseases.Transcutaneous electrical retinal stimulation therapy for age-related macular degeneration.Monoclonal antibodies based on hybridoma technology.Comparison of the effects of bevacizumab and ranibizumab injection on corneal angiogenesis in an alkali burn induced model.
P2860
Ranibizumab in neovascular age-related macular degeneration.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ranibizumab in neovascular age-related macular degeneration.
@en
Ranibizumab in neovascular age-related macular degeneration.
@nl
type
label
Ranibizumab in neovascular age-related macular degeneration.
@en
Ranibizumab in neovascular age-related macular degeneration.
@nl
prefLabel
Ranibizumab in neovascular age-related macular degeneration.
@en
Ranibizumab in neovascular age-related macular degeneration.
@nl
P2860
P921
P1476
Ranibizumab in neovascular age-related macular degeneration.
@en
P2093
Peter J Kertes
T Eng Kenneth
P2860
P304
P356
10.2147/CIIA.2006.1.4.451
P407
P577
2006-01-01T00:00:00Z